tiprankstipranks
Advertisement
Advertisement

SE:ORX Stock Latest News

Orexo posts positive in‑vivo data for nasal overdose reversal candidate OX390
Company AnnouncementsOrexo posts positive in‑vivo data for nasal overdose reversal candidate OX390
7d ago
Orexo AGM Backs Board, Expands Capital Flexibility and Incentive Plans
PremiumCompany Announcements
Orexo AGM Backs Board, Expands Capital Flexibility and Incentive Plans
19d ago
Orexo Deepens R&D Push as Losses Widen and Bond Redeemed Early
PremiumCompany Announcements
Orexo Deepens R&D Push as Losses Widen and Bond Redeemed Early
28d ago
Orexo updates share and voting structure after class C conversion
PremiumCompany Announcements
Orexo updates share and voting structure after class C conversion
2M ago
Orexo Calls 2026 AGM to Decide on Governance, Capital Measures and Incentive Plan
PremiumCompany Announcements
Orexo Calls 2026 AGM to Decide on Governance, Capital Measures and Incentive Plan
2M ago
Orexo Publishes 2025 Annual and Sustainability Reports Detailing Strategy and Market Position
PremiumCompany AnnouncementsOrexo Publishes 2025 Annual and Sustainability Reports Detailing Strategy and Market Position
2M ago
Orexo Restructures Leadership to Drive Pipeline and AmorphOX-Focused Growth
Premium
Company Announcements
Orexo Restructures Leadership to Drive Pipeline and AmorphOX-Focused Growth
3M ago
Orexo to Redeem SEK 500m Social Bonds After Zubsolv Rights Sale
Premium
Company Announcements
Orexo to Redeem SEK 500m Social Bonds After Zubsolv Rights Sale
3M ago
Orexo Adjusts Share Structure After U.S. Zubsolv Divestment
PremiumCompany Announcements
Orexo Adjusts Share Structure After U.S. Zubsolv Divestment
3M ago
Orexo Boosts Cash and Earnings After USD 91 Million Zubsolv US Sale
PremiumCompany Announcements
Orexo Boosts Cash and Earnings After USD 91 Million Zubsolv US Sale
4M ago
Orexo to Present New Strategy and AmorphOX Pipeline at March R&D Day
PremiumCompany Announcements
Orexo to Present New Strategy and AmorphOX Pipeline at March R&D Day
4M ago
Orexo to Present 2025 Full-Year Results with Focus on Zubsolv US Divestment
PremiumCompany Announcements
Orexo to Present 2025 Full-Year Results with Focus on Zubsolv US Divestment
4M ago
Orexo Completes Zubsolv US Rights Deal With Dexcel to Refocus on AmorphOX Pipeline
PremiumCompany AnnouncementsOrexo Completes Zubsolv US Rights Deal With Dexcel to Refocus on AmorphOX Pipeline
5M ago
Orexo Sells US Rights to Zubsolv to Dexcel to Repay Debt and Fund AmorphOX Pipeline
Premium
Company Announcements
Orexo Sells US Rights to Zubsolv to Dexcel to Repay Debt and Fund AmorphOX Pipeline
5M ago
Orexo AB’s Earnings Call: R&D Gains Amid Financial Hurdles
Premium
Company Announcements
Orexo AB’s Earnings Call: R&D Gains Amid Financial Hurdles
7M ago
Orexo AB Reports Q3 2025 Earnings and Strategic Developments
PremiumCompany Announcements
Orexo AB Reports Q3 2025 Earnings and Strategic Developments
7M ago
Orexo AB Reports Q3 2025 Financials and Secures BARDA Award
PremiumCompany Announcements
Orexo AB Reports Q3 2025 Financials and Secures BARDA Award
7M ago
ORXOF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ORXOF Upcoming Earnings Report: What to Expect?
7M ago
Orexo AB Announces Nomination Committee for 2026 AGM
PremiumCompany Announcements
Orexo AB Announces Nomination Committee for 2026 AGM
7M ago
Orexo AB to Present Q3 2025 Interim Report and Project Updates
PremiumCompany AnnouncementsOrexo AB to Present Q3 2025 Interim Report and Project Updates
7M ago
Orexo AB Enhances R&D with Strategic Move to Uppsala Science Park
Premium
Company Announcements
Orexo AB Enhances R&D with Strategic Move to Uppsala Science Park
8M ago
Orexo Secures $8 Million for OX390 Development from BARDA
Premium
Company Announcements
Orexo Secures $8 Million for OX390 Development from BARDA
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >